(November 19, 2015, 1:50 PM EST) -- PHILADELPHIA — A Pennsylvania state court Risperdal gynecomastia trial was stopped Nov. 18 to allow defendants Janssen Pharmaceuticals Inc. and Johnson & Johnson time to give the plaintiff data about a clinical study reanalysis, a source told Mealey Publications (Timothy Stange v. Janssen Pharmaceuticals, Inc., et al., No. 130401984, Pa. Comm. Pls., Philadelphia Co.)....